Liminatus Pharma, Inc. Made Headway
Thu, Aug 13, 2026 at 07:33 PM
Liminatus Pharma, Inc. (LIMN:NASDAQ) rocketted at $0.15, representing a gain of 38.2%. On Thu, Aug 13, 2026, LIMN:NASDAQ touched a New 2-Week High of $0.15. The stock appeared on our News Catalysts scanner on Thu, Aug 13, 2026 at 09:57 AM in the 'MISCELLANEOUS' category. From Thu, Jul 30, 2026, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Jul 16, 2026 at $0.2 with a volume of 578M+.
About Liminatus Pharma, Inc. (LIMN:NASDAQ)
Liminatus Pharma, Inc. is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies.
Top 10 Gainers:
- XChange TEC.INC (XHG:NASDAQ), 348.04%
- FGI Industries Ltd. (FGI:NASDAQ), 141.65%
- DEFSEC Technologies Inc Com (DFSC:NASDAQ), 86.29%
- Inno Holdings Inc. (INHD:NASDAQ), 57.33%
- Gaxos.ai Inc. (GXAI:NASDAQ), 44.74%
- Accelerant Holdings Class A (ARX:NYSE), 43.35%
- CuriosityStream Inc. (CURI:NASDAQ), 42.5%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 38.16%
- Ming Shing Group Holdings Limited (PMA:NASDAQ), 36.13%
- BeyondSpring Inc. (BYSI:NASDAQ), 34.27%